EcoDrugPlus

Ensembl ID : ML077645a
Gene Symbol: -
External references: -
548 Possible Orthologues:

Ensembl ID : ML078013a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML07801a
Gene Symbol: -
External references: -
73 Possible Orthologues:

Ensembl ID : ML07807a
Gene Symbol: -
External references: -
309 Possible Orthologues:

Ensembl ID : ML07823a
Gene Symbol: -
External references: -
60 Possible Orthologues:

Ensembl ID : ML07846a
Gene Symbol: -
External references: -
95 Possible Orthologues:

Ensembl ID : ML078924a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML078942a
Gene Symbol: -
External references: -
64 Possible Orthologues:

Ensembl ID : ML07925a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML079715a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML08063a
Gene Symbol: -
External references: -
95 Possible Orthologues:

Ensembl ID : ML082117a
Gene Symbol: -
External references: -
129 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).